Emergent BioSolutions
EBS
$3.17
Share price
-2.76%
Change (1 day)
-89.68%
Change (1 year)
Categories
Earnings for Emergent BioSolutions (EBS)
Earnings in 2023 (TTM): -$0.48 B
According to Emergent BioSolutions 's latest financial reports the company's current earnings (TTM) are -$0.48 B. In 2022 the company made an earning of -$0.19 B a decrease over its 2021 earnings that were of $0.34 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Emergent BioSolutions from 2004 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.48 B | 159.54% |
| 2022 | -$0.19 B | -152.85% |
| 2021 | $0.34 B | -20.43% |
| 2020 | $0.43 B | 278.02% |
| 2019 | $0.11 B | 26.86% |
| 2018 | $91.44 M | -26.98% |
| 2017 | $0.12 B | 51.35% |
| 2016 | $82.73 M | -14.07% |
| 2015 | $96.29 M | 57.08% |
| 2014 | $61.3 M | 41.31% |
| 2013 | $43.38 M | 35.25% |
| 2012 | $32.07 M | 0.39% |
| 2011 | $31.94 M | -56.46% |
| 2010 | $73.37 M | 76.73% |
| 2009 | $41.51 M | 38.74% |
| 2008 | $29.92 M | -9.57% |
| 2007 | $33.09 M | |
| 2005 | $47.91 M | 269.89% |
| 2004 | $12.95 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $24.22 B | -5,160.80% | 🇺🇸 USA |
 Merck MRK | $6.38 B | -1,434.52% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.96 B | -1,765.25% | 🇬🇧 UK |
 Soligenix SNGX | -$10.37 M | -97.83% | 🇺🇸 USA |
 SIGA Technologies SIGA | $35.75 M | -107.47% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$0.13 B | -74.66% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -$1.09 B | 125.87% | 🇮🇱 Israel |